## Study Design Selection for Rare Outcomes: VTE and Oral Contraceptives ### Why Case-Control is Preferred for Rare Outcomes **Key Point:** When investigating a rare outcome (like VTE), case-control design is preferred over cohort design, not the reverse. The question stem asks which statement is INCORRECT. **High-Yield:** - VTE incidence in women of reproductive age is approximately 1–2 per 10,000 person-years - This rarity makes cohort studies impractical (would need 100,000+ women followed for years) - Case-control studies are efficient: identify VTE cases and compare exposure history ### Correct Statements (Options 0, 1, 2) | Statement | Why Correct | |-----------|-------------| | **Option 0: Cohort study inefficiency** | VTE is rare; cohort requires huge sample and long follow-up to accumulate sufficient cases | | **Option 1: Case-control mechanism** | Case-control starts with outcome (VTE cases) and works backward to exposure (OCP use) | | **Option 2: OR approximates RR** | When outcome is rare (< 10%), OR ≈ RR; mathematically: OR = (a×d)/(b×c) ≈ RR when disease is rare | ### Why Option 3 is Incorrect **Warning:** Option 3 reverses the logic. It claims cohort is "preferred" for a rare outcome — this is backwards. - **Cohort studies** are preferred when the **outcome is common** or the **exposure is rare** - **Case-control studies** are preferred when the **outcome is rare** or the **exposure is common** **Clinical Pearl:** The VTE–OCP association was established through large case-control studies (e.g., Jick et al., WHO studies), not cohort studies, precisely because VTE is uncommon. ### Comparison Table: When to Use Each Design | Scenario | Preferred Design | Reason | |----------|-----------------|--------| | Rare outcome (VTE, cancer) | Case-control | Efficient; start with cases | | Common outcome (hypertension) | Cohort | Can measure incidence directly | | Rare exposure (occupational) | Cohort | Efficient; enroll exposed individuals | | Common exposure (smoking) | Case-control | Efficient; start with outcome | ### Decision Algorithm ```mermaid flowchart TD A[Study Question: Exposure → Outcome?]:::outcome --> B{Outcome Frequency?}:::decision B -->|Rare| C[Case-Control]:::action B -->|Common| D{Exposure Frequency?}:::decision D -->|Rare| E[Cohort]:::action D -->|Common| F[Either, prefer Case-Control]:::action C --> G[Identify cases with outcome<br/>Compare past exposure]:::action E --> H[Enroll exposed individuals<br/>Follow for outcomes]:::action ``` **Mnemonic: RARE OUTCOME → CASE-CONTROL** - Start with the **rare outcome** (cases) - Look **backward** at exposure - Much more **efficient** than cohort
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.